Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
HROW: Harrow Health, Inc. Stock Analysis | finqOS
Healthcare · Drug Manufacturers - Specialty & Generic
The Story
HROW
The Story
HROW
Loading chart data...
Current State
Balance holding
The verdict
Good business
Strong
Revenue growth
+53.3% / yr
Operating margin
10.5%
ROIC
8.5%
Financially safe
Stretched
Debt / equity
10.47×
Interest coverage
1.2×
Current ratio
2.48×
Harrow Health, Inc.
HROW
NASDAQ Global Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Harrow Health, Inc.
HROW
NASDAQ
·
USD
·
Closed
$38.77
−0.44%
$38.77
−$0.17 (0.44%)
52W Range
39th
pctl
Volume
0.30×
avg
Mkt Cap
1.45B
USD
P/E
-98.8
TTM
Div Yield
–
ann
52W Range
39th
pctl
Volume
0.30×
avg
Market Cap
1.45B
USD
P/E Ratio
-98.8
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings